BELLEROPHON THERAPEUTICS INC (BLPH)
US0787713009 - Common Stock
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!
MBLY Stock Alert: Morgan Stanley Restarts Mobileye Coverage
Mobileye (MBLY) stock is on the move Tuesday after Morgan Stanley analyst Adam Jonas renewed coverage of the company's shares.
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning!
7 Must-Have Stocks to Buy and Hold for a Secure Future
The best buy-and-hold stocks will help you take advantage of the power of compounding investing to help grow your wealth faster.
Stocks: AAPL rises all time-high; TGT falls on downgrade; PANW, TMBR gain; EPAM, BLPH down
During Monday's intraday session, major market indexes traded mixed as investors tried to assess the likelihood of the Fed hiking interest rates again next week.Looking at the...
AAPL rises to all time high; TGT falls on downgrade; PANW, TMBR gain; EPAM, BLPH slip
During Monday's intraday session, major market indexes traded mixed as investors tried to assess the likelihood of the Fed hiking interest rates again next week.Looking at the...
PLTR Stock Alert: Palantir Lands New Contract With U.S. Special Ops
Palantir Technologies (PLTR) stock is a hot topic among traders on Monday after securing a new $463 million contract with USSOCOM.
Why Is Bellerophon Therapeutics (BLPH) Stock Down 79% Today?
Bellerophon Therapeutics (BLPH) stock is taking a massive beating on Monday after the company posted poor clinical trial results.